(Q41508198)

1 October 2017

1 reference

title

EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment (English)

1 reference

1 October 2017

Liberati A

1

1 reference

1 October 2017

Sheldon TA

series ordinal

2

1 reference

1 October 2017

Banta HD

series ordinal

3

1 reference

1 October 2017

publication date

1 January 1997

1 reference

International Journal of Technology Assessment in Health Care

1 October 2017

published in

1 reference

1 October 2017

volume

13

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

186-219

1 reference

The friction cost method for measuring indirect costs of disease.

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

The journal's policy on cost-effectiveness analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Meta-analytic methods for diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Beware of surrogate outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Who benefits from medical interventions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Voltage-dependent potassium currents in ovine somatotrophs and their function in growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Sensitivity analysis in economic evaluation: a review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Health care technology as a policy issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

A brief perspective on cochlear implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Quality-adjusted life years, utility theory, and healthy-years equivalents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

Labeling of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Generalizing the results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Utilities and quality-adjusted life years

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

A method for the detailed assessment of the appropriateness of medical technologies

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Estimating costs in the economic evaluation of medical technologies

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Standardizing economic appraisal of health technology in the European Community

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Problems of using modelling in the economic evaluation of health care

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

The challenge of meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300010369

7 January 2021

10.1017/S0266462300010369

Identifiers

DOI

1 reference

1 October 2017

1 reference